So those are the types of things you do, you know, multiply that times 10 or 15 different opportunities with redundant vendors, with the ability to have some sort of negotiating power with our vendors of just raw materials. putting more and more products through our factory, and then even on the sales and marketing side to be able to have our clinicals travel less because the volume has increased across our portfolio in different cities, you know, with gas prices where they are and travel expenses where they are. That's a very, very meaningful part of the strategy, too, that doesn't hit our gross margin, but it's definitely going to help us on the sell-ex side of things.

May 13, 2026 / CEO / receipt, needs a key / Joe Burnett, CEO | earnings call 2026-05-13 | transcript 5642d319-240a-4ff9-b82b-cb3616ca9dcf | chars 26142-26821 | segment 26

This increase was due primarily to additional personnel costs, including share-based compensation, resulting from increases in headcount as well as increases in travel costs as we expanded our product and service offering.

May 7, 2024 / CEO / receipt, needs a key / Joe Burnett, CEO | earnings call 2024-05-07 | transcript 402e0aad-c974-4dfc-8bab-0715d1455f16 | chars 5396-5618 | segment 5